Pemigatinib is a kinase inhibitor primarily indicated for the treatment of adults with cholangiocarcinoma, a form of bile duct cancer, and other solid tumors harboring specific fibroblast growth factor… Read more









Pemigatinib is a kinase inhibitor primarily indicated for the treatment of adults with cholangiocarcinoma, a form of bile duct cancer, and other solid tumors harboring specific fibroblast growth factor receptor (FGFR) alterations. To support the rigorous demands of pharmaceutical analysis, this category provides a comprehensive collection of reference standards essential for analytical testing, impurity profiling, and method validation. Laboratories utilize these high-quality compounds, including the active pharmaceutical ingredient, related synthetic impurities, and degradation products, to ensure the accuracy of stability testing and quality control protocols. By incorporating accurately characterized standards—such as N-oxide and N-nitroso derivatives or other process-related substances—chemists can reliably identify and quantify impurities throughout the drug development lifecycle. These materials facilitate compliance with regulatory expectations, ensuring the safety and consistency of the final therapeutic product in complex analytical environments.